The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine

By Horie H.   Sato M.   Doi Y.   Hashizume S.  

Vaccine, Vol. 14, Iss. 1, 1996-01 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

By Robertson J.S.   Cook P.   Attwell A.-M.   Williams S.P.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1583-1588

Elsevier

Access to resources Recommend Favorite

Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model

By Wyatt L.S.   Shors S.T.   Murphy B.R.   Moss B.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1451-1458

Elsevier

Access to resources Recommend Favorite

Placebo-controlled evaluation of a modified life virus vaccine against feline infectious peritonitis: safety and efficacy under field conditions

By Fehr D.   Holznagel E.   Bolla S.   Hauser B.   Herrewegh A.A.P.M.   Horzinek M.C.   Lutz H.  

Vaccine, Vol. 15, Iss. 10, 1997-07 ,pp. : 1101-1109

Elsevier

Access to resources Recommend Favorite

Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)

By Dietzschold B.   Hooper D.C.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1656-1659

Elsevier

Access to resources Recommend Favorite